申请人:Moffat David Festus Charles
公开号:US20110039920A1
公开(公告)日:2011-02-17
Cyclopentyl(2S,4E)-2-amino-5-3-[4-carbamoyl-5(carbamoylamino)-2-thienyl]phenyl}pent-4-enoate; Cyclopentyl 5-3-[4-carbamoyl-5-(carbamoylamino)-2-thienyl]phenyl}-L-norvalinate; Cyclopentyl(2S,4E)-2-amino-5-3-[4-carbamoyl-5-(carbamoylamino)-2-thienyl]-5-methylphenyl}pent-4-enoate; Cyclopentyl(25,4E)-2-amino-5-5-[4-carbamoyl-5-(carbamoylamino)-2-thienyl]-2-methylphenyl}pent-4-enoate; Cyclopentyl O-3-[4-carbamoyl-5-(carbamoylamino)-2-thienyl]phenyl}-L-homoserinate; Cyclopentyl O-3-[4-carbamoyl-5-(carbamoylamino)-2-thienyl]phenyl}-L-homoserinate; Cyclopentyl N-3-[4-carbamoyl-5-(carbamoylamino)-2-thienyl]benzyl}-L-alaninate; and tert-Butyl N-3-[4-carbamoyl-5-(carbamoylamino)-2-thienyl]benzyl}-L-alaninate are hydrolysed to the corresponding carboxylic acids by intracellular carboxylesterases, and are useful for the inhibition of IKKβ activity.
环戊基(2S,4E)-2-氨基-5-3-[4-羰基-5-(羰基氨基)-2-噻吩基]苯基}戊-4-烯酸环戊基5-3-[4-羰基-5-(羰基氨基)-2-噻吩基]苯基}-L-正丙酸酯环戊基(2S,4E)-2-氨基-5-3-[4-羰基-5-(羰基氨基)-2-噻吩基]-5-甲基苯基}戊-4-烯酸环戊基(25,4E)-2-氨基-5-5-[4-羰基-5-(羰基氨基)-2-噻吩基]-2-甲基苯基}戊-4-烯酸环戊基O-3-[4-羰基-5-(羰基氨基)-2-噻吩基]苯基}-L-异亮氨酸酯环戊基O-3-[4-羰基-5-(羰基氨基)-2-噻吩基]苯基}-L-异亮氨酸酯环戊基N-3-[4-羰基-5-(羰基氨基)-2-噻吩基]苯基}-L-丙氨酸酯和叔丁基N-3-[4-羰基-5-(羰基氨基)-2-噻吩基]苯基}-L-丙氨酸酯通过细胞内羧酯酶水解为相应的羧酸,并且对IKKβ活性的抑制是有用的。